DJ Vertex Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Vertex Pharmaceuticals Inc. $(VRTX)$ advanced 1.94% to $515.55 Monday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.52% to 7,745.06 and Dow Jones Industrial Average falling 0.51% to 53,459.78.
The stock's rise snapped a three-day losing streak.
Vertex Pharmaceuticals Inc. closed 5.61% short of its 52-week high of $546.17, which the company reached on August 10th.
The stock outperformed some of its competitors Monday, as AbbVie Inc. $(ABBV)$ rose 0.35% to $250.33, Krystal Biotech Inc. (KRYS) rose 1.04% to $335.73, and Arcturus Therapeutics Holdings Inc. $(ARCT)$ fell 1.09% to $8.14.
Trading volume (1.1 M) remained 499,893 below its 50-day average volume of 1.6 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 17, 2026.